Accession Number: | 0001209191-20-040518 |
Date: | 2020-06-30 |
Issuer: | MARRONE BIO INNOVATIONS INC (MBII) |
Original Submission Date: |
MAGO YOGESH
C/O MARRONE BIO INNOVATIONS, INC.
1540 DREW AVENUE
DAVIS, CA 95618
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2020-06-30 | deemed execution date | A | 11,312 (a) | common stock 11,312 | $0.00 | 11,312 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2020-07-01 | deemed execution date | A | 23,148 (a) | common stock 23,148 | $0.00 | 23,148 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents a contingent right to receive one share of marrone bio innovations, inc. common stock. |
f2 | the restricted stock units vest with respect to 100% of the total shares subject to the grant on june 30, 2020. vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the company or immediately prior to a change in control event. |
f3 | the restricted stock units vest with respect to 100% of the total shares subject to the grant on may 31, 2021. vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the company or immediately prior to a change in control event. |